Skip to content
Screener

EBITDA at other companies

IAR
Integra LifeSciencesIART
$61.19M+113%
MiMedx Group logo
MiMedx GroupMDXG
-$18.18M-213%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$33K-98.0%
Axogen logo
AxogenAXGN
-$549K-116%
Solventum logo
SolventumSOLV
$314M-6.5%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$4.84M+23.0%

Other financials

Income statement

See full
Revenue$43.8M-56.7%
Gross profit$63.0M-22.5%
Operating income-$51.0M-305%
Net income-$96.3M-925%
EPS (diluted)-$0.77-670%

Balance sheet

See full
Cash & equivalents$46.1M-36.9%
Total debt$36.6M+19.2%
Total equity$148.3M-36.4%
Total assets$406.4M-11.9%

Cash flow

See full
Operating cash flow-$31.7M+3.7%
CapEx$1.1M-69.8%
Free cash flow-$32.8M+10.3%

Valuation

See full
Market cap$239.33M-59.1%
Enterprise value$229.8M-57.7%
P/S0.5×-0.8×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin-7.8%
Net margin-18.4%-20.8pp
FCF margin6.9%

Returns & leverage

See full
Return on equity-44.1%-48.0pp
Debt / equity0.2×+0.1×
Current ratio3.5×-0.4×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

$51.0Mebit+
$3.7MDepreciation Depletion & Amortization
=-$47.32M

The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338049

FAQ

What is Organogenesis Holdings Inc.'s EBITDA?
Organogenesis Holdings Inc. (ORGO) reported EBITDA of -$47.32M in Q2 2026.
How has Organogenesis Holdings Inc.'s EBITDA changed year-over-year?
Organogenesis Holdings Inc.'s EBITDA decreased by 435.2% year-over-year, from -$8.84M to -$47.32M.
What is the long-term trend for Organogenesis Holdings Inc.'s EBITDA?
Over 2 years (2021 to 2025), Organogenesis Holdings Inc.'s EBITDA has grown at a -15.0% compound annual growth rate (CAGR), from $82.95M to $59.97M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Organogenesis Holdings Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude